Skip to main content
. 2019 Feb 1;19:53. doi: 10.1186/s12888-019-2043-5

Table 2.

Stratified prevalence of lifetime, current, and past CAM use, and of willingness to try CAM

Prevalence in % (95% CI)
lifetime usea current use past use willingness to tryb
Sex
 Male 43.8 (35.8–52.0) 27.5 (20.6–35.2) 24.2 (17.6–31.8) 20.3 (14.2–27.5)
 Female 48.7 (32.4–65.2) 33.3 (19.1–50.2) 25.6 (13.0–42.1) 17.9 (7.5–33.5)
Age groups (in years)
 18–24 44.1 (31.2–57.6) 20.3 (11.0–32.8) 32.2 (20.6–45.6) 10.2 (3.8–20.8)
 25–34 40.3 (28.9–52.5) 30.6 (20.2–42.5) 18.1 (10.0–28.9) 20.8 (12.2–32.0)
  ≥ 35 50.8 (37.7–63.9) 34.4 (22.7–47.7) 24.6 (14.5–37.3) 27.9 (17.1–40.8)
Diagnoses
 Other ASD diagnosis 42.0 (31.1–53.5) 28.4 (18.9–39.5) 22.2 (13.7–32.8) 21.0 (12.7–31.5)
 Asperger syndrome 46.8 (37.3–56.6) 28.8 (20.6–38.2) 26.1 (18.2–35.3) 18.9 (12.1–27.5)
Intellectual functioning
 IQ < 85 42.6 (29.2–56.8) 31.5 (19.5–45.6) 25.9 (15.0–39.7) 16.7 (7.9–29.3)
 IQ ≥ 85 42.7 (33.9–51.9) 27.4 (19.8–36.2) 21.0 (14.2–29.2) 21.0 (14.2–29.2)
Level of education
 Low 44.6 (31.3–58.5) 32.1 (20.3–46.0) 25.0 (14.4–38.4) 17.9 (8.9–30.4)
 Medium 41.2 (27.6–55.8) 23.5 (12.8–37.5) 27.5 (15.9–41.7) 9.8 (3.3–21.4)
 High 47.1 (36.1–58.2) 29.4 (20.0–40.3) 22.4 (14.0–32.7) 27.1 (18.0–37.8)
 Overall 44.8 (37.6–52.1) 28.6 (22.4–35.6) 24.5 (18.6–31.2) 19.8 (14.4–26.1)

acontains all respondents who stated current use, past use or both

bcontains also respondents who stated that they already use or have used some other CAM modality